MJNA (Medical Marijuana) Total Receivables: $7.22 Mil (As of Dec. 2017)


What is Medical Marijuana Total Receivables?

Medical Marijuana MJNA -50.00% Total Receivables is $7.22 Mil as of Dec. 2017.

Medical Marijuana's Total Receivables for the quarter that ended in Dec. 2017 was $7.22 Mil.

Medical Marijuana Total Receivables Related Terms

Medical Marijuana Total Receivables Historical Data

* Premium members only.

The historical data trend for Medical Marijuana's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Marijuana Total Receivables Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Total Receivables
Get a 7-Day Free Trial 3.09 3.44 6.40 1.93 7.22

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Total Receivables Get a 7-Day Free Trial 3.09 3.44 6.40 1.93 7.22

Medical Marijuana Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $7.22 Mil mean?
Medical Marijuana (MJNA) has a Total Receivables of $7.22 Mil as of Dec. 2017. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Medical Marijuana and its competitors.
Is Medical Marijuana's Total Receivables too high?
Medical Marijuana's current Total Receivables is $7.22 Mil.
How does Medical Marijuana's Total Receivables compare to UPC and ERBB?
Medical Marijuana's Total Receivables of $7.22 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Medical Marijuana and its competitors. Medical Marijuana's current Total Receivables is $7.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Marijuana stock overvalued right now?
Medical Marijuana (MJNA) has a current Total Receivables of $7.22 Mil. The current Total Receivables is $7.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Medical Marijuana (MJNA), the current Total Receivables is $7.22 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Marijuana Business Description

Address 2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others. The company operates through Retail and Wholesale division; Direct Sales division; and Manufacturing and Production Division.